alpha-hydroxyglutarate has been researched along with Bile Duct Obstruction in 1 studies
2-hydroxyglutarate : A dicarboxylic acid anion obtained by deprotonation of at least one of the carboxy groups of 2-hydroxyglutaric acid.
2-hydroxyglutaric acid : A 2-hydroxydicarboxylic acid that is glutaric acid in which one hydrogen alpha- to a carboxylic acid group is substituted by a hydroxy group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tian, X | 3 |
| Wang, Y | 3 |
| Lu, Y | 3 |
| Wu, B | 3 |
| Chen, S | 3 |
| Du, J | 3 |
| Cai, W | 3 |
| Xiao, Y | 3 |
1 other study available for alpha-hydroxyglutarate and Bile Duct Obstruction
| Article | Year |
|---|---|
Metabolic regulation of cholestatic liver injury by D-2-hydroxyglutarate with the modulation of hepatic microenvironment and the mammalian target of rapamycin signaling.
Topics: Animals; Biliary Atresia; Cholestasis; Liver; Mammals; Mice; Sirolimus; TOR Serine-Threonine Kinases | 2022 |
Metabolic regulation of cholestatic liver injury by D-2-hydroxyglutarate with the modulation of hepatic microenvironment and the mammalian target of rapamycin signaling.
Topics: Animals; Biliary Atresia; Cholestasis; Liver; Mammals; Mice; Sirolimus; TOR Serine-Threonine Kinases | 2022 |
Metabolic regulation of cholestatic liver injury by D-2-hydroxyglutarate with the modulation of hepatic microenvironment and the mammalian target of rapamycin signaling.
Topics: Animals; Biliary Atresia; Cholestasis; Liver; Mammals; Mice; Sirolimus; TOR Serine-Threonine Kinases | 2022 |
Metabolic regulation of cholestatic liver injury by D-2-hydroxyglutarate with the modulation of hepatic microenvironment and the mammalian target of rapamycin signaling.
Topics: Animals; Biliary Atresia; Cholestasis; Liver; Mammals; Mice; Sirolimus; TOR Serine-Threonine Kinases | 2022 |
Metabolic regulation of cholestatic liver injury by D-2-hydroxyglutarate with the modulation of hepatic microenvironment and the mammalian target of rapamycin signaling.
Topics: Animals; Biliary Atresia; Cholestasis; Liver; Mammals; Mice; Sirolimus; TOR Serine-Threonine Kinases | 2022 |
Metabolic regulation of cholestatic liver injury by D-2-hydroxyglutarate with the modulation of hepatic microenvironment and the mammalian target of rapamycin signaling.
Topics: Animals; Biliary Atresia; Cholestasis; Liver; Mammals; Mice; Sirolimus; TOR Serine-Threonine Kinases | 2022 |
Metabolic regulation of cholestatic liver injury by D-2-hydroxyglutarate with the modulation of hepatic microenvironment and the mammalian target of rapamycin signaling.
Topics: Animals; Biliary Atresia; Cholestasis; Liver; Mammals; Mice; Sirolimus; TOR Serine-Threonine Kinases | 2022 |
Metabolic regulation of cholestatic liver injury by D-2-hydroxyglutarate with the modulation of hepatic microenvironment and the mammalian target of rapamycin signaling.
Topics: Animals; Biliary Atresia; Cholestasis; Liver; Mammals; Mice; Sirolimus; TOR Serine-Threonine Kinases | 2022 |
Metabolic regulation of cholestatic liver injury by D-2-hydroxyglutarate with the modulation of hepatic microenvironment and the mammalian target of rapamycin signaling.
Topics: Animals; Biliary Atresia; Cholestasis; Liver; Mammals; Mice; Sirolimus; TOR Serine-Threonine Kinases | 2022 |